Global Information
회사소개 | 문의 | 위시리스트

세계의 동물용 백신 시장

Veterinary Vaccines

리서치사 Global Industry Analysts, Inc.
발행일 2019년 05월 상품 코드 236741
페이지 정보 영문 309 Pages
가격
US $ 5,600 ₩ 6,694,000 PDF by E-mail (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 16,800 ₩ 20,082,000 PDF by E-mail (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 동물용 백신 시장 Veterinary Vaccines
발행일 : 2019년 05월 페이지 정보 : 영문 309 Pages

세계의 동물용 백신(Veterinary Vaccines) 시장에 대해 조사했으며, 시장 현황과 향후 성장 예측, 지역별 동향, 시장에 참여하는 기업 개요 등의 정보를 전해드립니다.

제1장 서론, 조사 방법, 정의

제2장 업계 개요

  • 시장 전망
  • 중요한 동물 질환
  • 동물용 백신 시장의 성장
  • 가축용 백신
  • 주요 백신
  • 성숙 시장과 신흥 시장
  • 기술에 근거한 시장
  • 시장 과제 등

제3장 성장 촉진요인과 시장 동향

  • 지속가능한 식품 공급 요구가 성장을 촉진
  • 개발도상국의 동물용 단백질 수요 증가
  • 애완동물 소유율 상승이 반려동물용 백신 수요를 촉진 등

제4장 제품 개요

  • 백신
  • 동물용 백신
  • 컨셉 개발
  • 백신 제조
  • 동물 의료의 중요 요소인 동물용 백신
  • 동물용 백신의 작용
  • 동물용 백신의 분류
  • 반려동물용 백신
  • 예방 접종과 반응 등

제5장 주요 동물 질환

제6장 경쟁 상황

  • 주요 기업
  • 제품 출시/인가
  • 최근의 업계 활동

제7장 세계 시장 전망

제8장 지역별 시장 전망

  • 미국
  • 유럽
  • 기타

제9장 기업 개요

KSM 18.10.25

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

This report analyzes the worldwide markets for Veterinary Vaccines in US$ by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 102 companies including many key and niche players such as -

Bayer AG
Biogenesis Bago SA
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Elanco Animal Health
Diamond Animal Health

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
  • A. Companion Animal Vaccines
  • B. Livestock Vaccines
      • Porcine Vaccines
      • Bovine Vaccines
      • Poultry Vaccines
      • Ovine Vaccines
      • Equine Vaccines
      • Other Animal Vaccines

2. INDUSTRY OVERVIEW

  • Market Outlook
  • Important Animal Diseases
  • Veterinary Vaccines Market on a Growth Trajectory
  • Livestock Vaccines Rule the Roost
  • Select Animal Disease Vaccines
  • Mature Markets Vis-a-vis Emerging Markets
  • Veterinary Vaccines Market based on Technology
  • -Live Attenuated Vaccines
  • -Killed/Inactivated Vaccines
  • -Recombinant vector vaccines
    • Table 1: Worldwide Veterinary Vaccines by Technology (2017): Market Share Breakdown (In %) for Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vector Vaccines, Toxoid Vaccines, and DNA Vaccines (includes corresponding Graph/Chart)
  • Recombinant DNA Technology to Take Over the Industry
  • Vector-based Vaccines
  • DNA Vaccines
  • Subunit and Virus-Like Particle (VLP)-based vaccines
  • Targeted Deletions/Modifications-based Vaccines
  • Collaborative R&D for Various Types of Veterinary Vaccines
  • Market Challenges

3. GROWTH DRIVERS AND MARKET TRENDS

  • Need to Ensure Sustainable Food Supply Spurs Growth
    • Table 2: Top Countries Worldwide in Terms of Population (July 2018) (in Million) (includes corresponding Graph/Chart)
    • Table 3: Worldwide Protein Consumption (kt): 2016-2020 (includes corresponding Graph/Chart)
  • Increasing Demand for Animal Protein in Developing Countries to Benefit the Market
    • Table 4: Per Capita Meat Consumption for Select Countries (In LB/per capita): 2017 (includes corresponding Graph/Chart)
  • Increasing Pet Ownership Drives Demand for Companion Animal Vaccines
    • Table 5: Global Pet Dog Population (2017): Number of Pet Dogs by Select Countries (in Millions) (includes corresponding Graph/Chart)
    • Table 6: Global Pet Cat Population (2017): Number of Pet Cats by Select Countries (in Millions) (includes corresponding Graph/Chart)
    • Table 7: Global Pet Birds Population (2017): Number of Pet Birds by Select Countries (in Millions) (includes corresponding Graph/Chart)
    • Table 8: Global Pet Fish Population (2017): Number of Pet Fish by Select Countries (in Millions) (includes corresponding Graph/Chart)
  • Spread of Zoonotic Diseases Propels Growth of Veterinary Vaccines
  • Social Concerns on Slaughtering Presents a Valid Case for Use of Vaccines
  • Novel Trends in Animal Vaccine Development
  • Reduced Response Time
  • Drug Resistance
  • Serotype Cross-Protection
  • Innovative Manufacturing
  • Technological Advancements
  • Porcine Market Offers Significant Prospects for Growth and New Vaccine Development
  • Select Swine Diseases
  • Select Key Marketed Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccines
  • Porcine Epidemic Diarrhea Virus (PEDV) Vaccines Available in Select Countries
  • Improvised Adjuvant Usage and Veterinary Vaccine Delivery Systems
  • Anthrax and Other Vaccines with Improved Adjuvants in the Pipeline
  • Matrix(tm) Adjuvant Technology by Novavax
  • Global Efforts to Conquer FMD by an Effective Vaccine
  • Member Countries with Endorsed Official Control Programme for FMD
  • FMD Free Zone Where Vaccination Is Practised
  • Foot-and-Mouth Disease Vaccines Available
  • Developments in the Poultry Vaccine Market
  • Vaccination - Critical for Controlling Avian Influenza Virus
    • Avian Influenza Vaccines
  • New Effervescent Tablets Vaccines against NDV - Augmenting Trend towards Convenient Administration
  • Vaccination in the Hatchery Gains Momentum
  • Parasitic Vaccines Segment Holds Potential
  • Egg-Derived Veterinary Vaccines in Human Vaccine Facilities
  • New Vaccine Strains - The Imminent Need in the Vaccine Market
  • The Need for Innovative Vaccine Delivery Mechanism Increasing
  • More Vaccines Needed to Prevent Zoonotic Infections
  • Plant-based Vaccines - the Next Avenue in Cost- effective and Efficacious Vaccines; Obstacles Persist Delaying Market Debut
  • Pricing Affects the Livestock Vaccine Market
  • Over-Vaccination Trend May Prove Harmful

4. PRODUCT OVERVIEW

  • Vaccines - An Evolutionary Scan
  • Veterinary Medicines - A Brief Review
  • Concept Development
  • Production of Vaccines
  • Veterinary Vaccines - An Essential Component of Animal Healthcare
  • What Does A Veterinary Vaccine Do?
  • Classification of Veterinary Vaccines
  • Companion Animal Vaccines
    • Canine Vaccines
      • Canine Distemper
      • Canine Parvovirus
      • Tracheobronchitis
      • Canine Coronavirus
      • Canine Leptospirosis
      • Canine Giardia
      • Canine Lyme borreliosis
      • Canine Rabies
    • Feline Vaccines
      • Feline Panleukopenia Virus Vaccine
      • Feline Calicivirus & Herpesvirus Vaccine
      • Rabies Virus Vaccine
      • Feline Leukemia Virus Vaccine
      • Chlamydia, Feline Infectious Peritonitis, and Ringworm Vaccines
    • Livestock Vaccines
    • Bovine Vaccines
      • Bovine virus diarrhoea - Mucosal disease (BVD-MD)
      • Johne's disease
      • Infectious Bovine Rhinotracheitis (IBR)
      • Blackleg
      • Neosporosis
    • Poultry Vaccines
    • Ovine Vaccines
    • Porcine Vaccines
    • Equine Vaccines
    • Aquaculture Vaccines
      • A Tabular Analysis on Select Animal Diseases Controlled by Vaccines
  • Vaccination and Its Reactions
  • Veterinary Vaccines - Latest Breakthroughs
  • Marker/DIVA Vaccines
  • DNA Vaccines
  • Gene-Deleted Vaccines
  • Viral-Vectored Vaccines

5. NOTES ON SELECT ANIMAL DISEASES

  • Brucellosis
  • Tuberculosis
  • Johne's disease
  • Spirochete Associated Diseases
  • Respiratory Disease in Goats, Sheep, and Cattle
  • Porcine Respiratory Diseases
  • Mastitis
  • African Swine Fever
  • Avian Influenza
  • East Coast Fever
  • Hemorrhagic Septicemia
  • Foot-And-Mouth Disease
  • Japanese Encephalitis
  • Rift Valley Fever
  • Equine Virus Infection

6. COMPETITIVE LANDSCAPE

  • 6.1 Focus on Select Key Players
  • Bayer AG (Germany)
  • Biogenesis Bago SA (Argentina)
  • Boehringer Ingelheim International GmbH (Germany)
  • Ceva Sante Animale (France)
  • Elanco Animal Health (USA)
  • Diamond Animal Health (USA)
  • Indian Immunologicals Ltd. (India)
  • Merck Animal Health (USA)
  • Virbac SA (France)
  • Zoetis Inc. (USA)
  • 6.2 Product Launches and Innovations
  • Elanco Animal Health Launches Novel Respiratory PRRS Vaccine
  • Merck Animal Health Launches SEQUIVITY(tm) Technology
  • Merck Animal Health Launches Updated Equine Influenza Vaccines
  • Hipra Introduces Smart Vaccination
  • Ceva Introduces New Technology Vaccines
  • Merial, Boehringer Introduces Needle-free Canine Vaccine
  • Zoetis Introduces Vanguard(r) CIV H3N2/H3N8 Vaccine
  • HIPRA Canada Animal Health Introduces ERYSENG(r) PARVO
  • MSD Animal Health Introduces First Live Poultry Vaccine
  • Aptimmune Introduces World's First Mucosal PRRSV Vaccine
  • AgriLabs Plans to Commercialize DNA Vaccine Platform
  • HIPRA Introduces STARTVAC(r) in Korea
  • MSD Animal Health Unveils PORCILIS PCV ID
  • Virbac Rolls Out Lepto4 Vaccine
  • 6.3 Recent Industry Activity
  • PHARMAQ Signs Agreement with Vinh Hoan for Pangasius Vaccine
  • Boehringer Ingelheim Announces Plans for Establishing Strategic Production Center for Veterinary Public Health in France
  • MSD Animal Health Announces Partnership with Vinovo to Enhance Poultry Health
  • Wageningen Bioveterinary Research Collaborates with Ceva Sante Animale to Develop Veterinary Vaccines
  • Zoetis Plans to Expand Animal Vaccine Research and Manufacturing in Suzhou, China
  • Boehringer Ingelheim Invests €65 Million in Avian Vaccines
  • Three Animal Health Companies Announces Joint Venture to Launch Vaccine for FMD in China
  • Huvepharma Acquires AgriLabs
  • Merck Animal Health Acquires Prondil S.A.
  • MSD Animal Health Agrees with Laboratorios LETI to Distribute LetiFend(r) Vaccine
  • MSD Animal Health Plans to Purchase New Manufacturing Facility in Krems, Austria
  • Ceva Phylaxia Completes the Inauguration of New European Vaccine Plant
  • Elanco Inaugurates Autogenous Poultry Vaccine Manufacturing Facility in Winslow, Maine
  • EU Authorizes First DNA Vaccine to Protect Against Salmon Pancreas Disease in Atlantic Salmon
  • Agrilabs Receives USDA Approval of the First DNA Vaccine for Chickens
  • Elanco Animal Health Acquires Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio
  • Ceva Sante Animale Agrees with EBVAC to Form a New Business Venture, Ceva EBVAC
  • Ceva Completes the Acquisition of Merial's Diversified Product Portfolio from Boehringer Ingelheim
  • IDT Biologika Acquires Ridgeway Biologicals Ltd
  • Boehringer Ingelheim Acquires Merial
  • PHARMAQ Acquires Nordland Sett Vak
  • Plumbline Life Sciences Receives License for Inovio's Foot and Mouth Disease DNA Vaccine
  • Bayer Teams Up with BioNTech for Development of Innovative Veterinary mRNA Vaccines
  • Harrisvaccines Secures Production Platform Vaccine Licensure from USDA
  • Orix to Acquire Kyoto Biken
  • Phibro to Take Over Vaccine Assets of MVP Laboratories

7. GLOBAL MARKET PERSPECTIVE

    • Table 9: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 10: World Historic Review for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 11: World 14-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 12: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 14: World 14-Year Perspective for Companion Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 15: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 17: World 14-Year Perspective for Companion Animal Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Canine Vaccines and Feline Vaccines Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 18: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 20: World 14-Year Perspective for Canine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 21: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 23: World 14-Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 24: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 25: World Historic Review for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 26: World 14-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 27: World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 29: World 14-Year Perspective for Livestock Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 30: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 32: World 14-Year Perspective for Porcine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 33: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 34: World Historic Review for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 35: World 14-Year Perspective for Bovine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 36: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 37: World Historic Review for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 38: World 14-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 39: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 40: World Historic Review for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 41: World 14-Year Perspective for Ovine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 42: World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 43: World Historic Review for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 44: World 14-Year Perspective for Equine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 45: World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 46: World Historic Review for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 47: World 14-Year Perspective for Other Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)

8. REGIONAL MARKET PERSPECTIVE

  • 8.1 The United States
  • A. Market Analysis
    • Food Safety Concerns and Biotechnological Offerings Drive the Veterinary Vaccines Market
      • List of Select Veternary Vaccines Available in the US
    • H5N1 Virus: A Conundrum for the US Industry
    • Increasing Pet Ownership - An Insight
    • Table 48: Pet Ownership in the US by Household Penetration Rate (1998- 2017) (includes corresponding Graph/Chart)
    • Table 49: Pet Ownership in the US by Generation (in %): 2017 (includes corresponding Graph/Chart)
    • Table 50: Pet Ownership in the US (2017): Number of Households that Own a Pet by Animal Type (in Millions) (includes corresponding Graph/Chart)
    • Table 51: US Pet Population (2017): Breakdown of Number of Pets by Category (in Millions) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 52: The US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 53: The US Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 54: The US 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.2 Europe
  • A. Market Analysis
    • Steady Market Growth Expected Due to Superior Livestock Management
    • List of Available Veterinary Vaccines in Europe
    • Regulations
    • EU Animal Welfare Strategy
  • B. Market Analytics
    • Table 55: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 56: European Historic Review for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 57: European 14-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 58: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 59: European Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 60: European 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.2.1 France
  • A. Market Analysis
    • Current & Future Analysis
  • B. Market Analytics
    • Table 61: French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 62: French Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 63: French 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.2.2 Germany
  • A. Market Analysis
    • Current & Future Analysis
    • Pet Population in Germany
    • Table 64: Pet Population in Germany by Type: 2017 (in Million) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 65: German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 66: German Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 67: German 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.2.3 Italy
  • Market Analysis
    • Table 68: Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 69: Italian Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 70: Italian 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.2.4 The United Kingdom
  • A. Market Analysis
    • Current & Future Analysis
    • Pet Population in the UK
    • Table 71: Pet Population in the UK by Type (2017) (In Million) (includes corresponding Graph/Chart)
    • Table 72: Percentage of Households with Pet in the UK by Pet Type (2017) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 73: The UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 74: The UK Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 75: The UK 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.2.5 Spain
  • Market Analysis
    • Table 76: Spanish Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 77: Spanish Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 78: Spanish 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.2.6 Rest of Europe
  • A. Market Analysis
    • Current & Future Analysis
    • A Review of Select Regional Markets
      • The Netherlands
      • Denmark
      • Russia Mass-Produces Vaccines against Avian Flu
  • B. Market Analytics
    • Table 79: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 80: Rest of Europe Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 81: Rest of Europe 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.3 Rest of World
  • A. Market Analysis
    • Current & Future Analysis
    • Focus on Select Markets
      • ASIA-PACIFIC
    • Table 82: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 83: Asia-Pacific Historic Review for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 84: Asia-Pacific 14-Year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
      • CHINA
      • Increased Livestock Output and Emerging Pet Industry Lead to Higher Vaccine Demand
    • Table 85: Chinese Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 86: Chinese Historic Review for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 87: Chinese 14-Year Perspective for Veterinary Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Poultry Vaccines, and Others Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
      • Growing Pet Industry Holds Promise
      • Threat of Avian Influenza Outbreaks Creates Market for Effective Vaccine
      • Demand for Higher-Quality Swine Fever Vaccine
      • Demand for Effective PRRS Vaccines by Foreign Manufacturers
      • FMD Epidemics Cause Increased demand for Vaccine
      • Effective Rabies Vaccine Needed to Curb Dog Menace
      • Highly Consolidated Chinese Veterinary Market
      • REST OF ASIA-PACIFIC
      • India
      • Animal Vaccines Market to Surge
    • Table 88: Indian Animal Health Products Market by Segment (2017): Percentage Breakdown of Value Sales for Feed Supplements, Therapeutics and Vaccines (includes corresponding Graph/Chart)
      • Major Players
      • New Opportunities Exist despite Well Established Market
    • Table 89: Indian Veterinary Vaccines Market by Segment (2017): Percentage Breakdown of Value Sales for Companion Animals, Livestock and Poultry (includes corresponding Graph/Chart)
      • NORTH KOREA
      • TAIWAN
      • Taiwan's Animal Healthcare Industry under Scan
      • AUSTRALIA
      • A Note on Australian Veterinary Therapeutics Market
      • Sizing the Market
    • Table 90: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines Market Analyzed in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 91: Rest of Asia-Pacific Historic Review for Veterinary Vaccines Market Analyzed in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
      • LATIN AMERICA
      • Current & Future Analysis
    • Table 92: Latin American Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 93: Latin American Historic Review for Veterinary Vaccines by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 94: Latin American 14-Year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
      • CANADA
      • Overview of the Canadian Animal Health Industry
      • Imports and Manufacture of Veterinary Biologics
      • First to Access E. coli 0157:H7 Vaccine
  • B. Market Analytics
    • Table 95: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 96: Rest of World Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 97: Rest of World 14-Year Perspective for Veterinary Vaccines by Product Group/ Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)

9. COMPANY PROFILES Total Companies Profiled: 94 (including Divisions/Subsidiaries - 110) The United States (21) Canada (1) Japan (6) Europe (28) - France (5) - Germany (5) - The United Kingdom (5) - Italy (2) - Spain (4) - Rest of Europe (7) Asia-Pacific (Excluding Japan) (31) Middle East (4) Latin America (14) Africa (5)

Back to Top
전화 문의
F A Q